These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3964532)

  • 1. The effect of chloroquine on paracetamol disposition and kinetics.
    Adjepon-Yamoah KK; Woolhouse NM; Prescott LF
    Br J Clin Pharmacol; 1986 Mar; 21(3):322-4. PubMed ID: 3964532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dependence of paracetamol absorption on the rate of gastric emptying.
    Heading RC; Nimmo J; Prescott LF; Tothill P
    Br J Pharmacol; 1973 Feb; 47(2):415-21. PubMed ID: 4722050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method.
    Adithan C; Thangam J
    Br J Clin Pharmacol; 1982 Jul; 14(1):107-9. PubMed ID: 7104162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.
    Prescott LF; Speirs GC; Critchley JA; Temple RM; Winney RJ
    Eur J Clin Pharmacol; 1989; 36(3):291-7. PubMed ID: 2744070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological studies in a Distalgesic addict.
    Roberts I; Flanagan RJ; Strang J; Prescott LF
    Hum Toxicol; 1986 May; 5(3):207-10. PubMed ID: 3710498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contributions of various chloroquine salts to the biliary and urinary execretion of hepatic paracetamol conjugation metabolites in the rat.
    Oforah E; Anyogo S
    Drug Metabol Drug Interact; 2000; 16(2):129-41. PubMed ID: 10962645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracetamol metabolism after general anaesthesia.
    Lewis RP; Dunphy JA; Reilly CS
    Eur J Anaesthesiol; 1991 Nov; 8(6):445-50. PubMed ID: 1765042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.
    Andreasen PB; Hutters L
    Acta Med Scand Suppl; 1979; 624():99-105. PubMed ID: 284720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracetamol (acetaminophen) kinetics in patients with Gilber's syndrome.
    Douglas AP; Savage RL; Rawlins MD
    Eur J Clin Pharmacol; 1978 May; 13(3):209-12. PubMed ID: 668775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose primaquine has no effect on paracetamol clearance.
    Back DJ; Tjia JF
    Eur J Clin Pharmacol; 1987; 32(2):203-5. PubMed ID: 3582486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a single dose of ethanol on pharmacokinetics of paracetamol.
    Wójcicki J; Baśkiewicz Z; Gawrońska-Szklarz B; Kazimierczyk J; Kałucki K
    Pol J Pharmacol Pharm; 1978; 30(6):749-53. PubMed ID: 755241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
    Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
    Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracetamol metabolism in chronic liver disease.
    Forrest JA; Adriaenssens P; Finlayson ND; Prescott LF
    Eur J Clin Pharmacol; 1979 Jul; 15(6):427-31. PubMed ID: 499292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chrysin on the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes.
    Pingili RB; Pawar AK; Challa SR
    Chem Biol Interact; 2019 Apr; 302():123-134. PubMed ID: 30794797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of paracetamol and its conjugates in Chinese non-insulin-dependent diabetic patients with renal impairment.
    Chan MT; Anderson PJ; Chan JC; Lau GS; Critchley JA
    Eur J Clin Pharmacol; 1997; 52(4):285-8. PubMed ID: 9248766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.
    Liu DJ; Collaku A
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):77-86. PubMed ID: 28815997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases.
    Wójcicki J; Gawrońska-Szklarz B; Kazimierczyk J; Baskiewicz Z; Raczyński A
    Arzneimittelforschung; 1979; 29(2):350-2. PubMed ID: 582149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relative bioavailability of paracetamol in suppositories in comparison to tablets].
    Blume H; Ali SL; Elze M; Krämer J; Scholz ME
    Arzneimittelforschung; 1996 Oct; 46(10):975-80. PubMed ID: 8992964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the metabolism of paracetamol by isoniazid.
    Epstein MM; Nelson SD; Slattery JT; Kalhorn TF; Wall RA; Wright JM
    Br J Clin Pharmacol; 1991 Feb; 31(2):139-42. PubMed ID: 2049229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary paracetamol elimination kinetics during the menstrual cycle.
    Somaja L; Thangam J
    Br J Clin Pharmacol; 1987 Mar; 23(3):348-50. PubMed ID: 3567050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.